Ibsrela Side Effects
Generic Name: tenapanor
Medically reviewed by Drugs.com. Last updated on July 29, 2020.
Note: This document contains side effect information about tenapanor. Some of the dosage forms listed on this page may not apply to the brand name Ibsrela.
For the Consumer
Applies to tenapanor: oral tablets
Side effects include:
For Healthcare Professionals
Applies to tenapanor: oral tablet
The most commonly reported side effects included diarrhea, abdominal distention, flatulence, and dizziness.[Ref]
Very common (10% or more): Diarrhea (up to 20%)
Common (1% to 10%): Abdominal distention, flatulence, severe diarrhea
Diarrhea occurred in 20% of patients with renal dysfunction (estimated glomerular function rate [eGFR] less than 90 mL/min/1.73 m2), compared to 16% of patients without renal dysfunction.[Ref]
In a clinical trial with patients with type 2 diabetes mellitus and chronic kidney disease (eGFR 25 to 70 mL/min/1.73 m2), hyperkalemia resulting in hospitalization was reported in 2 patients given this drug and 1 patient given placebo.[Ref]
Common (1% to 10%): Dizziness[Ref]
1. "Product Information. Ibsrela (tenapanor)." Ardelyx, Inc, Fremont, CA.
More about Ibsrela (tenapanor)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.